Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
MaxCyte ( (MXCT) ) has issued an update.
MaxCyte, Inc., a non-UK issuer, has been notified of a significant change in holdings by BlackRock, Inc., a leading investment management company based in Wilmington, DE, USA. As of December 16, 2024, BlackRock has crossed a voting rights threshold, now holding 7.99% of MaxCyte’s total voting rights, slightly down from a previous position of 8.44%. This adjustment in BlackRock’s position reflects an acquisition or disposal of voting rights, highlighting ongoing shifts in shareholder composition that could impact MaxCyte’s governance and influence among stakeholders.
More about MaxCyte
YTD Price Performance: -2.70%
Average Trading Volume: 46,337
Technical Sentiment Consensus Rating: Sell
Current Market Cap: £354.4M
Learn more about MXCT stock on TipRanks’ Stock Analysis page.
